ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ambrx gets orphan drug designation for gastric cancer treatment ARX788
March 23, 2021The US Food and Drug Administration (FDA) grants orphan drug designation to Ambrx for ARX788, a homogeneous and highly stable antibody drug conjugate, for the treatment of HER2-positive gastric cancer. -
FDA grants ARX788 fast track designation for HER2-positive metastatic breast cancer
January 07, 2021Ambrx announced that the US Food and Drug Administration (FDA) granted ARX788 Fast Track Designation as monotherapy for the treatment of advanced or metastatic HER2-positive breast cancer patients who have received one or more prior anti-HER2 based ...
Pharma Sources Insight January 2025
